ZEUS Scientific Acquires Synthetic Peptides from Sheba Medical Center's Tech Transfer Co.
29. Oktober 2021 08:30 ET
|
ZEUS Scientific
BRANCHBURG, N.J., Oct. 29, 2021 (GLOBE NEWSWIRE) -- ZEUS Scientific has obtained exclusive, worldwide rights to the use of these synthetic peptides as targets of disease-specific autoantibodies in...